WO2001083682A3 - Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001083682A3
WO2001083682A3 PCT/CN2001/000635 CN0100635W WO0183682A3 WO 2001083682 A3 WO2001083682 A3 WO 2001083682A3 CN 0100635 W CN0100635 W CN 0100635W WO 0183682 A3 WO0183682 A3 WO 0183682A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
discloses
pax protein
human pax
Prior art date
Application number
PCT/CN2001/000635
Other languages
English (en)
Chinese (zh)
Other versions
WO2001083682A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Shanghai Biowindow Gene Dev
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Dev, Yumin Mao, Yi Xie filed Critical Shanghai Biowindow Gene Dev
Priority to AU67282/01A priority Critical patent/AU6728201A/en
Publication of WO2001083682A2 publication Critical patent/WO2001083682A2/fr
Publication of WO2001083682A3 publication Critical patent/WO2001083682A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une protéine Pax humaine 11.6, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine Pax humaine 11.6.
PCT/CN2001/000635 2000-04-29 2001-04-28 Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide WO2001083682A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU67282/01A AU6728201A (en) 2000-04-29 2001-04-28 A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115558.X 2000-04-29
CN 00115558 CN1321680A (zh) 2000-04-29 2000-04-29 一种新的多肽——人Pax蛋白11.6和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001083682A2 WO2001083682A2 (fr) 2001-11-08
WO2001083682A3 true WO2001083682A3 (fr) 2002-03-14

Family

ID=4585004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000635 WO2001083682A2 (fr) 2000-04-29 2001-04-28 Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1321680A (fr)
AU (1) AU6728201A (fr)
WO (1) WO2001083682A2 (fr)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B.W. SCHAFER ET AL.: "Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes", NUCLEIC ACIDS RES., vol. 22, no. 22, 11 November 1994 (1994-11-11), pages 4574 - 4582 *
M. GERARD ET AL.: "PAX-genes expression during human embryonic development, a preliminary report", C.R. ACAD. SCI. III, vol. 318, no. 1, January 1995 (1995-01-01), pages 57 - 66 *
P. SANYANUSIN ET AL.: "Genomic structure of the human PAX2 gene", GENOMICS, vol. 35, no. 1, 1 July 1996 (1996-07-01), pages 258 - 261 *

Also Published As

Publication number Publication date
WO2001083682A2 (fr) 2001-11-08
AU6728201A (en) 2001-11-12
CN1321680A (zh) 2001-11-14

Similar Documents

Publication Publication Date Title
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001075048A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s11 23, et polynucleotide codant pour ce polypeptide
WO2001083687A3 (fr) Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide
WO2002000821A3 (fr) Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2002000828A3 (fr) Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide
WO2001083683A3 (fr) Nouveau polypeptide, proteine pax humaine 11.3, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001075057A3 (fr) Nouveau polypeptide, proteine ribosomale s4 humaine 12, et polynucleotide codant pour ce polypeptide
WO2001064866A1 (fr) Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001075035A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075034A3 (fr) Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide
WO2001075028A3 (fr) Nouveau polypeptide, proteine ribosomale humaine s4-12, et polynucleotide codant pour ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001083685A3 (fr) Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide
WO2001075039A3 (fr) Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001077287A3 (fr) Nouveau polypeptide, globine humaine de l'uterus 11, et polynucleotide codant pour ce polypeptide
WO2001075043A3 (fr) Nouveau polypeptide, proteine kinase humaine 9 adn-dependante, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2001079428A3 (fr) Nouveau polypeptide, proteine humaine de reparation 8.9 du mesappariement de l'adn, et polynucleotide codant pour ce polypeptide
WO2001075024A3 (fr) Nouveau polypeptide, facteur humain 13 associe a nf-e2, et polynucleotide codant pour ce polypeptide
WO2001081538A3 (fr) Nouveau polypeptide, connexine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001081536A3 (fr) Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP